OBJECT: The goal of this study was to evaluate short- and long-term benefits in quality of life (QOL) after unilateral deep brain stimulation (DBS) for essential tremor (ET). METHODS: Patients who received unilateral DBS of the ventral intermediate nucleus of the thalamus between 1997 and 2010 and who had at least 1 follow-up evaluation at least 1 year after surgery were included. Their QOL was assessed with the Parkinson Disease Questionnaire-39 (PDQ-39), and ET was measured with the Fahn-Tolosa-Marin tremor rating scale (TRS) prior to surgery and then postoperatively with the stimulation in the on mode. RESULTS: Ninety-one patients (78 at 1 year; 42 at 2-7 years [mean 4 years]; and 22 at >7-12 years [mean 9 years]) were included in the analysis. The TRS total, targeted tremor, and activities of daily living (ADL) scores were significantly improved compared with presurgical scores up to 12 years. The PDQ-39 ADL, emotional well-being, stigma, and total scores were significantly improved up to 7 years after surgery compared with presurgical scores. At the longest follow-up, only the PDQ-39 stigma score was significantly improved, and the PDQ-39 mobility score was significantly worsened. CONCLUSIONS: Unilateral thalamic stimulation significantly reduces ET and improves ADL scores for up to 12 years after surgery, as measured by the TRS. The PDQ-39 total score and the domains of ADL, emotional well-being, and stigma were significantly improved up to 7 years. Although scores were improved compared with presurgery, other than stigma, these benefits did not remain significant at the longest (up to 12 years) follow-up, probably related in part to changes due to aging and comorbidities.
OBJECT: The goal of this study was to evaluate short- and long-term benefits in quality of life (QOL) after unilateral deep brain stimulation (DBS) for essential tremor (ET). METHODS:Patients who received unilateral DBS of the ventral intermediate nucleus of the thalamus between 1997 and 2010 and who had at least 1 follow-up evaluation at least 1 year after surgery were included. Their QOL was assessed with the Parkinson Disease Questionnaire-39 (PDQ-39), and ET was measured with the Fahn-Tolosa-Marin tremor rating scale (TRS) prior to surgery and then postoperatively with the stimulation in the on mode. RESULTS: Ninety-one patients (78 at 1 year; 42 at 2-7 years [mean 4 years]; and 22 at >7-12 years [mean 9 years]) were included in the analysis. The TRS total, targeted tremor, and activities of daily living (ADL) scores were significantly improved compared with presurgical scores up to 12 years. The PDQ-39 ADL, emotional well-being, stigma, and total scores were significantly improved up to 7 years after surgery compared with presurgical scores. At the longest follow-up, only the PDQ-39 stigma score was significantly improved, and the PDQ-39 mobility score was significantly worsened. CONCLUSIONS: Unilateral thalamic stimulation significantly reduces ET and improves ADL scores for up to 12 years after surgery, as measured by the TRS. The PDQ-39 total score and the domains of ADL, emotional well-being, and stigma were significantly improved up to 7 years. Although scores were improved compared with presurgery, other than stigma, these benefits did not remain significant at the longest (up to 12 years) follow-up, probably related in part to changes due to aging and comorbidities.
Authors: Theresa A Zesiewicz; Jessica D Shaw; Kevin G Allison; Joseph S Staffetti; Michael S Okun; Kelly L Sullivan Journal: Curr Treat Options Neurol Date: 2013-08 Impact factor: 3.598
Authors: Masa-aki Higuchi; Dan D Topiol; Bilal Ahmed; Hokuto Morita; Samuel Carbunaru; Christopher W Hess; Dawn Bowers; Herbert E Ward; Lisa R Warren; Meredith M DeFranco; Michelle S Troche; Shankar J Kulkarni; Erin Hastings; Kelly D Foote; Michael S Okun; Daniel Martinez-Ramirez Journal: PLoS One Date: 2015-12-28 Impact factor: 3.240
Authors: Marc N Gallay; David Moser; Franziska Rossi; Payam Pourtehrani; Anouk E Magara; Milek Kowalski; Alexander Arnold; Daniel Jeanmonod Journal: J Ther Ultrasound Date: 2016-02-13
Authors: Robert S Eisinger; Joshua Wong; Leonardo Almeida; Adolfo Ramirez-Zamora; Jackson N Cagle; Juan C Giugni; Bilal Ahmed; Alberto R Bona; Erin Monari; Aparna Wagle Shukla; Christopher W Hess; Justin D Hilliard; Kelly D Foote; Aysegul Gunduz; Michael S Okun; Daniel Martinez-Ramirez Journal: Mov Disord Clin Pract Date: 2017-11-27
Authors: Maria Fiorella Contarino; Paul F C Groot; Johan N van der Meer; Lo J Bour; Johannes D Speelman; Aart J Nederveen; Pepijn van den Munckhof; Marina A J Tijssen; Peter Rick Schuurman; Anne-Fleur van Rootselaar Journal: PLoS One Date: 2012-10-01 Impact factor: 3.240